Pharma channel feed – Endpoints News

Pharma channel feed

CSL Behring says uptake of hemophilia B gene therapy slower than expected

9 months ago

Galderma wins FDA approval for IL-31 drug in chronic skin disease

9 months ago

Lawmakers renew calls for government to finalize march-in guidance

9 months ago

J&J receives support for $6.5B talc settlement — report

9 months ago

Pressure from anti-China legislation begins to ripple through biopharma

9 months ago

Legend continues Carvykti factory builds to cement CAR-T territory with J&J

9 months ago

Three papers on MDMA are retracted by medical journal, just a day after Lykos' FDA rejection

9 months ago

Ascendis scores FDA approval for hypoparathyroidism candidate to replace Takeda's pulled drug

9 months ago

Pfizer touts strength of RSV vaccine in subgroup of younger immunocompromised patients

9 months ago

Lykos’ MDMA-assisted PTSD treatment rejected by FDA after troubled trial and pushback from experts

10 months ago

Ohio federal judge dismisses IRA suit brought by US Chamber of Commerce

10 months ago

Amgen announces plans for new site in India to strengthen AI, data and life sciences

10 months ago

Hello, neffy: FDA approves first nasal spray for severe allergic reactions

10 months ago

Alfasigma's PBC treatment Ocaliva to face an FDA adcomm in September

10 months ago

23andMe trades drug discovery for GLP-1 weight loss prescriptions

10 months ago

Novavax plots to reduce European footprint to become a ‘leaner’ company

10 months ago

Merck pays $700M for clinical-stage CD3xCD19 bispecific antibody

10 months ago

Gilead shells out $320M to J&J to buy out rare liver disease drug royalties

10 months ago

Purdue’s emergency opioid overdose treatment is approved by the FDA

10 months ago

Lilly says to ‘take some caution’ on other companies’ early-stage obesity data, calls out compounders

10 months ago

FDA approves Citius Pharma's non-Hodgkin lymphoma drug Lymphir

10 months ago

Amneal Pharma's extended-release Parkison's treatment clinches FDA approval

10 months ago

Q&A: PhRMA CEO Stephen Ubl on the IRA, challenges to the FDA’s authority and the US-China relationship

10 months ago

Lilly crushes expectations with GLP-1 franchise, as supply constraints ease

10 months ago

First page Previous page 41 42 434445 46 47 Next page Last page